Pulse Width Programming in Spinal Cord Stimulation: A Clinical Study

被引:0
|
作者
Yearwood, Thomas L. [1 ]
Hershey, Brad [2 ]
Bradley, Kerry [2 ]
Lee, Dongchul [2 ]
机构
[1] Comprehens Pain & Rehabil, Pascagoula, MS 39581 USA
[2] Boston Sci Neuromodulat, Valencia, CA USA
关键词
Spinal cord stimulation; pulse width; paresthesia; dermatome; implantable pulse generator; neurostimulation; chronic pain; neuropathic; dorsal column; dorsal root; chronaxie; ELECTRICAL-STIMULATION; INTRACTABLE PAIN; EXCITABLE TISSUE; DORSAL; PERFORMANCE; ADJUSTMENT; EXPERIENCE; DURATION; DESIGN; FIBERS;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: With advances in spinal cord stimulation (SCS) technology, particularly rechargeable implantable, patients are now being offered a wider range of parameters to treat their pain. In particular, pulse width (PW) programming ranges of rechargeable implantable pulse generators now match that of radiofrequency systems (with programmability up to 1000 mu s). The intent of the present study was to investigate the effects of varying PW in SCS. Objective: To understand the effects of PW programming in spinal cord stimulation (SCS). Design: Single-center, prospective, randomized, single-blind evaluation of the technical and clinical outcomes of PW programming. Setting: Acute, outpatient follow-up. Methods: Subjects using fully-implanted SCS for > 3 months to treat chronic intractable low back and/or leg pain. Programming of a wide range (50-1000 mu s) of programmed PW settings using each patient's otherwise unchanged 'walk-in' program. Outcome Measures: Paresthesia thresholds (perception, maximum comfortable, discomfort), paresthesia coverage and patient choice of tested programs. Results: We found strength-duration parameters of chronaxie and rheobase to be 295 (242 - 326) mu s and 2.5 (1.3 - 3.3) mA, respectively. The median PW of all patients' 'walk-out' programs was 400 mu s, approximately 48% higher than median chronaxie (P = 0.01), suggesting that chronaxie may not relate to patient-preferred stimulation settings. We found that 7/19 patients selected new PW programs, which significantly increased their paresthesia-pain overlap by 56% on average (P = 0.047). We estimated that 10/19 patients appeared to have greater paresthesia coverage, and 8/19 patients appeared to display a 'caudal shift' of paresthesia coverage with increased PW. Limitations: Small number of patients Conclusions: Variable PW programming in SCS appears to have clinical value, demonstrated by some patients improving their paresthesia-pain overlap, as well as the ability to increase and even 'steer' paresthesia coverage.
引用
收藏
页码:321 / 335
页数:15
相关论文
共 50 条
  • [31] Spinal cord stimulation
    Moore, D. M.
    McCrory, C.
    BJA EDUCATION, 2016, 16 (08) : 258 - 263
  • [32] Spinal cord stimulation
    Simpson, BA
    BRITISH JOURNAL OF NEUROSURGERY, 1997, 11 (01) : 5 - 11
  • [33] CLINICAL OUTCOME OF SPINAL CORD STIMULATION FOR SPINAL DISORDER RELATED TO PARKINSON DISEASE
    Park, C. K.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E17 - E17
  • [34] The role of the opioid system in the clinical tolerance of spinal cord stimulation
    Raffaeli, W
    Ingardia, A
    MANAGEMENT OF ACUTE AND CHRONIC PAIN: THE USE OF THE TOOLS OF THE TRADE, 2000, : 717 - 723
  • [35] Impact of Tailoring Spinal Cord Stimulation Therapy on Clinical Outcomes
    Patel, Vipul Vikrambhai
    Cook, Steven
    Kent, Alexander
    Dalal, Nirav
    Karst, Edward
    Lad, Shivanand
    JOURNAL OF NEUROSURGERY, 2015, 123 (02) : A516 - A516
  • [36] CLINICAL RESULTS OF PATIENTS TREATED WITH SPINAL-CORD STIMULATION
    ILLIS, LS
    SEDGWICK, EM
    TALLIS, RC
    THORNTON, ARD
    GARFIELD, J
    SCHWEIZER ARCHIV FUR NEUROLOGIE UND PSYCHIATRIE, 1978, 123 (01): : 97 - 97
  • [37] A Review of Clinical Data on Salvage Therapy in Spinal Cord Stimulation
    Wolter, Tilman
    Pittelkow, Thomas
    Osborne, Michael
    NEUROMODULATION, 2020, 23 (05): : 570 - 571
  • [38] Burst Spinal Cord Stimulation in Pregnancy: First Clinical Experiences
    Meier, Kaare
    Glavind, Julie
    Milidou, Ioanna
    Sorensen, Jens Christian Hedemann
    Sandager, Puk
    NEUROMODULATION, 2023, 26 (01): : 224 - 232
  • [39] Clinical value of spinal cord stimulation for peripheral vascular disease
    Gersbach, P
    Gardaz, JP
    Hayoz, D
    von Segesser, LK
    PROCEEDINGS OF THE 14TH CONGRESS OF THE EUROPEAN CHAPTER OF THE INTERNATIONAL UNION OF ANGIOLOGY, 2001, : 153 - 158
  • [40] Spinal cord stimulation: Cost-benefit study
    Budd, K
    NEUROMODULATION, 2002, 5 (02): : 75 - 78